Oestrogenic and androgenic activity of triclosan in breast cancer cells
暂无分享,去创建一个
A. Charles | P. Darbre | R. Gee | N. Taylor | P. Darbre | R H Gee | A Charles | N Taylor | P D Darbre | Amelia K. Charles | R. H. Gee
[1] C. Osborne,et al. Biological differences among MCF-7 human breast cancer cell lines from different laboratories , 2005, Breast Cancer Research and Treatment.
[2] Hiromichi Yoshikawa,et al. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR. , 2006, Bioorganic & medicinal chemistry.
[3] R. Daly,et al. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. , 1990, Cancer research.
[4] H. Shiratsuchi,et al. Effects of triclosan on the early life stages and reproduction of medaka Oryzias latipes and induction of hepatic vitellogenin. , 2004, Aquatic toxicology.
[5] G. S. Pope,et al. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[6] M. Beato,et al. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. , 1986, The EMBO journal.
[7] P. Darbre,et al. 3,4,3',4'-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. , 1996, Molecular endocrinology.
[8] R. King,et al. Steroid hormone regulation of cultured breast cancer cells. , 1988, Cancer treatment and research.
[9] A. Howell,et al. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. , 2004, Best practice & research. Clinical endocrinology & metabolism.
[10] N. Sato,et al. Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumor (Shionogi carcinoma 115) , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[11] J. Readman,et al. Photolytic degradation of triclosan in freshwater and seawater. , 2007, Chemosphere.
[12] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .
[13] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[14] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[15] P. Rigby,et al. High efficiency gene transfer into mammalian cells. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[16] L. Guillette. Endocrine Disrupting Contaminants—Beyond the Dogma , 2005, Environmental health perspectives.
[17] D. Sabaliūnas,et al. Environmental fate of Triclosan in the River Aire Basin, UK. , 2003, Water research.
[18] J. Bayona,et al. Monitoring the photochemical degradation of triclosan in wastewater by UV light and sunlight using solid-phase microextraction. , 2006, Chemosphere.
[19] Hing-Biu Lee,et al. Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. , 2005, Journal of chromatography. A.
[20] P. Darbre,et al. Changes in oestrogen receptor-α and -β during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[21] T. Ohyama,et al. Acute toxicity, percutaneous absorption and effects on hepatic mixed function oxidase activities of 2,4,4′-trichloro-2′-hydroxydiphenyl ether (Irgasan® DP300) and its chlorinated derivatives , 1992, Archives of environmental contamination and toxicology.
[22] C. Sonnenschein,et al. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[23] Maria Pettersson,et al. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. , 2002, Chemosphere.
[24] P. Darbre,et al. Effect of estradiol on human breast cancer cells in culture. , 1983, Cancer research.
[25] M. Parker. Nuclear hormone receptors : molecular mechanisms, cellular functions, clinical abnormalities , 1991 .
[26] A. Pike. Lessons learnt from structural studies of the oestrogen receptor. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[27] P. Darbre. Environmental oestrogens, cosmetics and breast cancer. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[28] G. Sandborgh-Englund,et al. Determination of triclosan as its pentafluorobenzoyl ester in human plasma and milk using electron capture negative ionization mass spectrometry. , 2006, Analytical chemistry.
[29] Juliette Legler,et al. Identification of estrogenic compounds in fish bile using bioassay-directed fractionation. , 2004, Environmental science & technology.
[30] R. King,et al. Androgen regulation by the long terminal repeat of mouse mammary tumor virus , 1986, Molecular and cellular biology.
[31] V. Anderson,et al. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells , 2002, Cancer Chemotherapy and Pharmacology.
[32] W. Benson,et al. Developmental evaluation of a potential non-steroidal estrogen: triclosan. , 2000, Marine environmental research.
[33] B. Hammock,et al. Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. , 2007, Toxicology and applied pharmacology.
[34] M. Gunderson,et al. The bactericidal agent triclosan modulates thyroid hormone-associated gene expression and disrupts postembryonic anuran development. , 2006, Aquatic toxicology.
[35] G. S. Pope,et al. Oestrogenic activity of isobutylparaben in vitro and in vivo , 2002, Journal of applied toxicology : JAT.
[36] Michael S McLachlan,et al. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. , 2006, The Science of the total environment.
[37] H. Takada,et al. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. , 2006, Water research.
[38] C. Ciniglia,et al. Application of methods for assessing the geno- and cytotoxicity of Triclosan to C. ehrenbergii. , 2005, Journal of hazardous materials.
[39] L. Hovander,et al. Identification of Hydroxylated PCB Metabolites and Other Phenolic Halogenated Pollutants in Human Blood Plasma , 2002, Archives of environmental contamination and toxicology.
[40] P. Harvey,et al. Regulation of Endocrine-disrupting Chemicals: Critical Overview and Deficiencies in Toxicology and Risk Assessment for Human Health , 2022 .
[41] G. S. Pope,et al. Oestrogenic activity of benzylparaben , 2003, Journal of applied toxicology : JAT.
[42] W. Wahli,et al. Structure and Function of the Estrogen Receptor , 1999 .
[43] Kurtis Sarafin,et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. , 2006, The Science of the total environment.
[44] R. Sharpe. Pathways of endocrine disruption during male sexual differentiation and masculinization. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[45] R Cela,et al. Determination of parabens and triclosan in indoor dust using matrix solid-phase dispersion and gas chromatography with tandem mass spectrometry. , 2007, Analytical chemistry.
[46] P. Darbre,et al. Multihormone regulation of MMTV-LTR in transfected T-47-D human breast cancer cells. , 1989, Journal of steroid biochemistry.
[47] G. Sandborgh-Englund,et al. Pharmacokinetics of Triclosan Following Oral Ingestion in Humans , 2006, Journal of toxicology and environmental health. Part A.
[48] Guang-Guo Ying,et al. Triclosan in wastewaters and biosolids from Australian wastewater treatment plants. , 2007, Environment international.
[49] H. Shiratsuchi,et al. Effects of nonylphenol and triclosan on production of plasma vitellogenin and testosterone in male South African clawed frogs (Xenopus laevis). , 2005, Biological & pharmaceutical bulletin.
[50] D. Howes,et al. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[51] R. Leake,et al. Steroid Hormones: A Practical Approach , 1989 .
[52] G. S. Pope,et al. Oestrogenic activity of parabens in MCF7 human breast cancer cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[53] Weida Tong,et al. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. , 2003, Chemical research in toxicology.
[54] A. Dayan. Risk assessment of triclosan [Irgasan] in human breast milk. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[55] M. C. Archer,et al. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. , 2004, Carcinogenesis.